CGM accuracy in pregnancy study
Part of Hormones & metabolism clinical trials.
This study checks how well two continuous glucose monitors (CGM) work during pregnancy for women with diabetes. It aims to see if they provide accurate readings to help manage blood sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and have type 1, type 2, or gestational diabetes that was diagnosed before your 32nd week of pregnancy
- You are at least 18 years old
- You are willing to wear two continuous glucose monitors (CGM) at the same time
- You have a smartphone that works with the LibreLink app
- You are able to give your informed consent to take part in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
This trial tests whether a continuous glucose monitor can help women with type 2 diabetes who are pregnant and need insulin therapy. It aims to improve blood sugar control and pregnancy outcomes.
This study compares two ways to check blood sugar during pregnancy in women with gestational diabetes: a small sensor worn on the skin that tracks glucose continuously, versus traditional finger-stick testing. The goal is to see which method helps women manage their blood sugar better and have healthier pregnancies.
This trial tests whether using a continuous glucose monitor (CGM) during pregnancy and after delivery helps women with gestational diabetes. It aims to see if the Dexcom G7 can improve health outcomes for both you and your baby.
This study tests whether using a CGM (a small sensor that tracks blood sugar) can help manage type 2 diabetes during pregnancy better than standard care. It is for women who have type 2 diabetes and are pregnant with one baby.
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
Hear when a new Pregestational Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.